The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
HILLEVAX INC COM 43157M102   983,704 558,923 SH   SOLE   558,923 0 0
JASPER THERAPEUTICS INC COM NEW 471871202   17,473,813 928,964 SH   SOLE   928,964 0 0
KEZAR LIFE SCIENCES INC COM 49372L100   638,107 828,711 SH   SOLE   828,711 0 0
KORRO BIO INC COM 500946108   12,301,401 368,085 SH   SOLE   368,085 0 0
TOURMALINE BIO INC COM 89157D105   19,068,876 741,691 SH   SOLE   741,691 0 0
VENTYX BIOSCIENCES INC COM 92332V107   898,651 412,225 SH   SOLE   412,225 0 0